J&J has received a marketing authorization for its OTTAVA robot

AI Summary Johnson & Johnson has officially obtained the green light to enter the U.S. robotic surgery market, currently dominated by Intuitive Surgical. The $600 billion market cap company has been granted a De Novo authorization for its OTTAVA™ Robotic Surgical System by the U.S. Food and Drug Administration (FDA), according to a Wednesday announcement. J&J said... fulltext: 367 chars | fulltext source: rss-fallback | summary method: extractive Original: https://www.cryptopolitan.com/johnson-johnson-fda-authorization-for-robot/ Source: CryptoPolitan